|Day's Range||93.50 - 96.26|
The coronavirus continues to sweep across the world. It's hitting Europe and the U.S. hard after the outbreak began in China. Despite the hellish reality of Covid-19, we're seeing individual companies step up, like Gilead Sciences (NASDAQ:GILD). As a result, GILD stock is up 16.3% year-to-date and 9% over the past month.Some investors may look at that and say, "so what?"But compare that to the SPDR S&P 500 ETF (NYSEARCA:SPY), which is down 22% and 15.3% in the same time frame and you can understand why Gilead has stood out. It's also why it has the potential to shine even brighter in the coming weeks and months.InvestorPlace - Stock Market News, Stock Advice & Trading Tips Gilead vs. Covid-19The virus is bringing out the best in many American companies. Ford (NYSE:F), General Motors (NYSE:GM) and Tesla (NASDAQ:TSLA) are producing ventilators. Gap (NYSE:GPS), Ralph Lauren (NYSE:RL) and others are producing scrubs, gowns and other supplies. Breweries are making hand sanitizer. We're stepping up. And so is biotech. * 10 Stocks to Buy Whose Companies We Can't Live Without Gilead is working on a Covid-19 treatment with a drug called remdesivir. On March 23, the FDA granted remdesivir "orphan status." That designation would, among other things, give it exclusivity rights. However, just a few days later Gilead filed with the FDA to remove that status. Click to Enlarge Source: Chart courtesy of Statista, Source from WHO The company said it could maintain an "expedited timeline" without the status, and that the designation is meant to apply for infections impacting less than 200,000 Americans. With more than 215,000 confirmed coronavirus cases in the U.S. and growing rapidly, it's clear the number will be far higher.Gilead CEO Daniel O'Day recently said that remdesivir is "a medicine we had been studying for many years as part of our extensive research in antivirals … Multiple studies are ongoing, and we are on track to have initial data in the coming weeks."On April 1, the company initiated two Phase 3 trials for remdesivir for use in patients with moderate to severe Covid-19.This is all moving along very quickly. If Gilead sees promising results, not only is that huge for Gilead but it's huge for the world. We need some sort of positive catalyst here. Not just for the stock market, but for humanity. People are growing tired of being on lockdown orders and anxiety is creeping higher for many out of work.If Gilead's remdesivir works, it could be a game changer. Sizing Up GILD Stock Click to Enlarge Source: Chart courtesy of StockCharts.comA glance at the chart above highlights what life has been like for long-term investors in Gilead. Simply put, the stock has been a painful one to own. Shares embarked on a brutal decline from a high north of $100 in 2015 to a low near $57.50 in 2017. It has since been trying to carve out a bottom.Shares moved slowly but constructively higher in 2019, leading to a breakout in 2020. Of course, that's on the back of the company's remdesivir hopes, putting Gilead in a somewhat binary situation.Binary situations are generally unattractive from an investment perspective, particularly when they center around a treatment being accepted or rejected. As it stands though, investors may be safe buying a pullback into the $65 to $70 area. As long as GILD stays above $65, its technicals are in good shape.On the upside, look for a rally back up to resistance between $77.50 to $80. A breakout over $80 puts the recent highs near $86 on the table.While Gilead shares has been hammered over the years, its fundamentals have deteriorated a bit over that time as well. But -- and this is a big but -- Gilead Sciences is not your typical fly-by-night binary biotech play. It's a low valuation, cash-rich healthcare titan.The company boasts $24.3 billion in cash -- $19.4 billion including its recent acquisition of Forty Seven (NASDAQ:FTSV). Trailing free cash flow is north of $8.3 billion, with revenue and net income of $22.4 billion and $5.4 billion, respectively. Gilead may not be in its prime, but it's a very profitable machine.Investors could do worse than pay 11.3 times this year's earnings for a company like Gilead, with the upside kicker being remdesivir.Matthew McCall left Wall Street to actually help investors -- by getting them into the world's biggest, most revolutionary trends BEFORE anyone else. The power of being "first" gave Matt's readers the chance to bank +2,438% in Stamps.com (STMP), +1,523% in Ulta Beauty (ULTA) and +1,044% in Tesla (TSLA), just to name a few. Click here to see what Matt has up his sleeve now. Matt does not directly own the aforementioned securities. More From InvestorPlace * 25 Stocks You Should Sell Immediately * 1 Under-the-Radar 5G Stock to Buy Now * This Stock Picker's Latest Video Just Went Viral * The 1 Stock All Retirees Must Own The post Gilead Sciencesa Coronavirus Treatment Has Big-Time Potential appeared first on InvestorPlace.
Looking for any sign of normalcy during these tumultuous times? Any sign at all?Source: Shutterstock Well, you may be glad to know that during this moment of incredible uncertainty on Wall Street, the stock market is actually following some fairly familiar patterns.We all know that the U.S. economy fluctuates between periods of expansion and contraction. Sometimes those fluctuations last a few years, and sometimes they last a little longer.InvestorPlace - Stock Market News, Stock Advice & Trading TipsWe've all been spoiled for the past decade because the expansionary period -- and the related bull market -- lasted for so long.However, all expansions eventually come to an end, and it looks like we're at the end of the most recent expansion.The good news is that all contractions also eventually come to an end, so we can all be on the lookout for it. Hopefully it's not too far around the bend.So, what are we seeing now in the stock market, and what should everybody be looking for in the future to identify the bullish turn? Sector Rotation in the S&P 500Historically -- remember, we've seen market corrections before -- when the stock market pulls back, defensive sectors, like healthcare, consumer staples and utilities, tend to outperform.Similarly, when the stock market starts to bottom out, more aggressive sectors, like financials, consumer discretionary and technology, tend to outperform.The business cycle chart in Fig. 1 illustrates the relationship between the stages of the cycle -- expansion and contraction in the economy -- and the stock market sectors that tend to outperform during each stage of the cycle.Source: Chart by InvestorPlace Fig. 1 -- Sector Rotation during the Business CycleSo, what's happening now?Since the S&P 500 hit its peak on Feb. 19, every sector in the market has experienced a double-digit percentage drop.However, some sectors have outperformed others during the bear-market reversal. Can you guess which ones? Which Sectors Are Outperforming?Let's look at a comparison chart of the S&P 500 and the 10 S&P 500 sectors as represented by the Select Sector SPDR exchange-traded funds (ETFs). These ETFs are tracked by State Street Global Advisors.Here's the breakdown of the performance of each fund in the sector-comparison chart in Fig. 2: * Health Care Select Sector SPDR Fund (NYSEARCA:XLV): -17.2% * Consumer Staples Select Sector SPDR Fund (NYSEARCA:XLP): -17.3% * Technology Select Sector SPDR Fund (NYSEARCA:XLK): -23% * Utilities Select Sector SPDR Fund (NYSEARCA:XLU): -24.1% * SPDR S&P 500 Fund (NYSEARCA:SPY): -26% * Consumer Discretionary Select Sector SPDR Fund (NYSEARCA:XLY): -28.1% * Materials Select Sector SPDR Fund (NYSEARCA:XLB): -28.2% * Real Estate Select Sector SPDR Fund (NYSEARCA:XLRE): -29.4% * Industrial Select Sector SPDR Fund (NYSEARCA:XLI): -32.6% * Financial Select Sector SPDR Fund (NYSEARCA:XLF): -36.2% * Energy Select Sector SPDR Fund (NYSEARCA:XLE): -49%Source: Chart courtesy of TradingView Fig. 2 -- SPDR Sector ETFs Comparison Chart, Mid-March to AprilAs you can see, three of the top four performing sectors during the past six weeks are healthcare, consumer staples and utilities.This is exactly what we would expect to see.So, why is this good news?It's good news because even though we don't know exactly what is going to happen next in the novel coronavirus pandemic, we can be quite confident that Wall Street is going to behave like it has during past pullbacks.That means we can put the odds in our favor by making trades that are informed by history.It also means we can watch the financial, consumer discretionary and technology sectors for signs of a turnaround in the future and be confident in what we're seeing. The Bottom LineWe haven't seen the end of the volatility on Wall Street. Every new revision in the United States' potential Covid-19 death toll will bring swings in the stock market.However, we can navigate these choppy waters. We've got a few historical lighthouses on the shore serving as markers that we can watch to avoid the rocks.John Jagerson & Wade Hansen are just two guys with a passion for helping investors gain confidence -- and make bigger profits with options. In just 15 months, John & Wade achieved an amazing feat: 100 straight winners -- making money on every single trade. If that sounds like a good strategy, go here to find out how they did it. John & Wade do not own the aforementioned securities. More From InvestorPlace * 25 Stocks You Should Sell Immediately * 1 Under-the-Radar 5G Stock to Buy Now * This Stock Picker's Latest Video Just Went Viral * The 1 Stock All Retirees Must Own The post Finding Predictability Amid the Uncertainty on Wall Street appeared first on InvestorPlace.
Executive Summary: Two weeks ago we predicted that the U.S. death toll from COVID-19 would reach 20,000 by April 15th. The following article explains why. Article: I am furious and frustrated. Once the greatest country on the face of this planet, the United States is going hat in hand to China, begging for a […]
'This surprisingly high level of bullishness supports our own view that we haven't yet seen investor capitulation, echoing what we've seen in other data sets,' writes RBC's head of U.S. equity strategy Lori Calvasina.
As analysts and economists take stock of the degree of damage the COVID-19 pandemic is likely to inflict on the economy, an economist at BofA Securities said the ensuing recession is poised to "take the crown."Record Recession Forecasted The recession resulting from the pandemic is likely to be deeper and more prolonged, not just in the U.S. but globally as well, BofA's U.S. economist Michelle Meyer said in a Thursday note.The economist estimates GDP will contract for three consecutive quarters until the third quarter. The U.S. economy is expected to shrink 7% at a quarter-over-quarter, seasonally adjusted annual rate in the first quarter, 30% in the second quarter and 1% in the third quarter, she said. Benzinga is covering every angle of how the coronavirus affects the financial world. For daily updates, sign up for our coronavirus newsletter.How Various Components of GDP Could Fare The first quarter will be hurt by a severe decline in consumer spending in the second half of March, enough to push the quarter into contraction, Meyer said. The weakness in consumer spending is likely to broaden in April, with Meyer estimating a 40% drop in spending in the second quarter. The economist also said the sharp rise in unemployment insurance claims conjures up the scenario of income loss and impairment of consumer spending.The weakness will further be exacerbated by a decline in business investment, according to BofA. While consumer spending is projected to limp back to normalcy and turn positive in the third quarter as the economy opens up, there is likely to be further contraction in business and residential investment, Meyer said.There will be additional inventory contraction amid impaired supply chains and frictions in production, she said. Meyers said she expects the unemployment rate to peak at 15.6%."We forecast the cumulative decline in GDP to be 10.4% and this will be the deepest recession on record, nearly five times more severe than the post-war average." Light At the End of Tunnel BofA does see a recovery on the other side. After solving the public health crisis and stopping the spread of the pandemic, the next step is to slowly open the economy, with businesses returning and people going back to work, Meyer said. This will unleash pent-up demand, leading to a 30% pop in fourth-quarter GDP, she said. "Nonetheless, we think this will be a slow recovery overall as many workers will be displaced and businesses adapt to a period of lost revenue." Related Links:Will The COVID-19 Economic Shutdown Teach Americans To Save More Money? Jobless Claims And The Likely Collapse Of Volumes - FreightWaves NOW See more from Benzinga * Companies Suspend Dividends, Buybacks As Pandemic Weakens Market * From Record Highs To Bear Market In 21 Days: BofA Says To Avoid Panic Selling, Focus On Quality Stocks * Coronavirus Threat To Global Growth Is 'Real' And Shouldn't Be Ignored, Analysts Say(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Stocks rose Thursday as investors shook off earlier concerns after the U.S. Labor Department’s report on weekly unemployment insurance claims far exceeded expectations.
New U.S. jobless claims for the week ending March 27 totaled a whopping 6.648 million versus a 3.5-million estimate, according to numbers reported Thursday by the Bureau of Labor Statistics.The initial jobless claims in the week ending March 20 reached 3.283 million.It is estimated that unemployment claims are likely to remain high in the coming weeks, as many states haven't fully processed all unemployment-benefit applications due to the deluge, reports The Wall Street Journal.Benzinga is covering every angle of how the coronavirus affects the financial world. For daily updates, sign up for our coronavirus newsletter.Constance Hunter, chief economist at KPMG LLP, told the Journal that she estimates 20 million jobs will be lost as a result of the coronavirus pandemic. "We didn't see this in the global financial crisis. We didn't see this in the Great Depression. There's been a total decimation of consumption."Last week, President Donald Trump signed a $2-trillion stimulus package into law. Related Link:New US Jobless Claims Hit Record 3.28M As Coronavirus Strikes EconomySee more from Benzinga * New US Jobless Claims Hit Record 3.28M As Coronavirus Strikes Economy * Oil Claws Its Way Back Up, Analyst Projects Startling Q2 Surplus * IRS Tax Deadline Extended To July 15, Mnuchin Says(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Satori Fund founder Dan Niles warned his clients about coronavirus before it hit the market. Now, he's warning we haven't bottomed.
Stocks started the second quarter off on the wrong foot, tumbling lower on the day. That said, here's a look at a few top stock trades now. Top Stock Trades for Tomorrow No. 1: Microsoft (MSFT) Click to Enlarge Source: Chart courtesy of StockCharts.comMicrosoft (NASDAQ:MSFT), the largest holding in the SPDR S&P 500 ETF (NYSEARCA:SPY), is starting to roll over. Shares failed to hold up over the 100-day moving average and were swiftly rejected by the 50-day moving average.Let's see how the stock does on a slightly deeper decline, down to the $150 mark and the 200-day moving average. If this zone fails to buoy the stock, more downside could be in a store.InvestorPlace - Stock Market News, Stock Advice & Trading TipsI would love to see another test of $140 to see how Microsoft holds up. If $140 steps in as support, MSFT should avoid a retest of the lows near $135. Below both levels puts $130 in play. A pullback to prior resistance that holds as support is not only healthy price action, but would be a constructive development as investors get a higher low to work with.On the upside, though, see if the stock can reclaim its 100-day moving average. Above that, and the 50-day moving average is in play. Top Stock Trades for Tomorrow No. 2: S&P 500 ETF (SPY) Click to Enlarge Source: Chart courtesy of StockCharts.comSpeaking of the SPY ETF, let's take a closer look at the stock. Last night I flagged a very similar chart, but also highlighted that SPY was failing at its 200-week moving average. On the daily chart above, you can see that the 20-day moving average acted as resistance, as did the 38.2% retracement for the 2020 decline (which is also the 52-week range). Shares are now struggling to hold the less-important 23.6% retracement. Below that mark and the Q4 2018 lows near $233.75 are in play. If those hold, bulls may view it as a buy-the-dip opportunity with a higher low in place. If it fails to hold, it puts the 2020 lows in play just below $220. Top Stock Trades for Tomorrow No. 3: AT&T (T) Click to Enlarge Source: Chart courtesy of StockCharts.comAt the start of the selloff, AT&T (NYSE:T) was holding up okay. But the selling pressure got to this stock, too -- which has since fallen below $30. It's had trouble reclaiming this mark, as it moves down into the upper $20s. Last week, the $26 mark propelled shares higher, but a retest of that low isn't out of the question right now. If that level breaks, the $25 mark is in play, which as has been multi-year support for some time now. On the upside, however, let's see if AT&T can reclaim $31. Above that puts its 100-week and 200-week moving averages in play between $32 and $32.50. Above that and the mid-$30s are on the table. Top Stock Trades for Tomorrow No. 4: Peleton (PTON) Click to Enlarge Source: Chart courtesy of StockCharts.comThere was no love for Peloton (NASDAQ:PTON) when the company went public in September. Up almost 10% on Wednesday and after surging from its lows near $18 in March, PTON is clearly back in favor. The stock is approaching its $29 IPO price, which has been resistance over the past few months. Above this mark and downtrend resistance currently near $31.50 is in play. Above that and $34 is possible. On a pullback, see if Peloton can find support between $24 and $25. Below puts $21 on the table. Below that and the March lows are in play, where buyers previously stepped in over several sessions. Bret Kenwell is the manager and author of Future Blue Chips and is on Twitter @BretKenwell. As of this writing, Bret Kenwell is long T. More From InvestorPlace * 25 Stocks You Should Sell Immediately * 1 Under-the-Radar 5G Stock to Buy Now * This Stock Picker's Latest Video Just Went Viral * The 1 Stock All Retirees Must Own The post 4 Top Stock Trades for Thursday: MSFT, AT&T, PTON, SPY appeared first on InvestorPlace.
President Donald Trump signed a $2-trillion stimulus package last week that will send most Americans up to $1,200 in direct payment as a lifeline during the coronavirus (COVID-19) economic shutdown.Americans in financial need now have plenty of questions about the stimulus checks and how to maximize the amount of money they receive.About The Stimulus The biggest question on most Americans' minds is when will they receive their money. The Treasury Department said all Americans with direct deposit information on file with the IRS should receive their payments within three weeks. The government is also reportedly working on a web-based portal to allow individuals to provide banking information for direct deposits.Those who have not provided direct deposit information will receive stimulus checks in the mail. The Treasury has historically taken between six and eight weeks to mail checks, but officials expect the stimulus check process will be expedited.At this point, Americans in need of financial assistance should ensure they are doing what they can to maximize their payout. The stimulus payouts are $1,200 for an individual with $75,000 or less in adjusted gross income or $2,400 for married couples with $150,000 or less in adjusted gross income. Americans also get an additional $500 for each child dependent.Benzinga is covering every angle of how the coronavirus affects the financial world. For daily updates, sign up for our coronavirus newsletter.Maximizing Your Stimulus The individual stimulus amount phases out incrementally for individuals earning more than $75,000 and couples earning more than $150,000. The IRS is using the most current tax returns available to determine adjusted gross income.For Americans who have already filed 2019 returns, 2019 returns will be used. For all others, 2018 tax returns will be used.Rebecca McElroy, tax partner at Maddox, Thomson & Associates in Houston, told Benzinga that Americans should consider the implications that filing their 2019 tax returns early could have on their stimulus payments."Individuals who wouldn't qualify for relief based on 2018 adjusted gross income should file their 2019 returns as soon as possible," McElroy told Benzinga.At the same time, McElroy said certain individuals who earned more than $75,000 and couples who earned more than $150,000 in adjusted gross income in 2019 may benefit from delaying their 2019 filing until the stimulus payments go out."If 2019 adjusted gross income is anticipated to exceed these thresholds but an individual or married couple would otherwise qualify for full payment based on 2018 income, defer filing the 2019 return until the extended July 15th due date," she said.Major Financial Changes? As a general rule of thumb, McElroy told Benzinga that any American who experienced a major financial change in 2018 or 2019 should consider reaching out to a tax professional.For example, McElroy was able to help a single mother of two children that was divorced in 2019 file her 2019 tax return early, putting her in line for a large stimulus check that she wouldn't have otherwise received.In 2018, the woman filed jointly with her husband, and the couple earned a combined $235,000 in income, making her ineligible for a stimulus payment."Her income as a single filer in 2019 was $48,000 and she was eligible to claim both children under the age of 10 as dependents for 2019. I told her, 'let's get your 2019 return filed right away!' In doing so, she will now receive $3,400 as opposed to zero." Benzinga's Take The stimulus package was created and will be enacted rapidly in a chaotic environment. In order to maximize your potential payout and minimize the possibility of mistakes, Americans should understand 2019 tax filing implications, add or verify that the IRS has direct deposit information on file and confirm that the amount of stimulus is correct based on personal income and family status.Do you agree with this take? Email email@example.com with your thoughts.Related Links:Will The COVID-19 Economic Shutdown Teach Americans To Save More Money? 10 Best Ways To Use Your ,200 Stimulus CheckSee more from Benzinga * Will The COVID-19 Economic Shutdown Teach Americans To Save More Money? * Markets End Historically Volatile Week On Uneven Note * Why Stock Exchange Floor Closings Could Be Creating End-Of-Day Volatility(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
While the full impact of COVID-19 on the global economy is still unknowable, we are gaining perspective on its economic impact, and thus its investment implications Continue reading...
President Donald Trump prepares Americans for more difficult days ahead as the coronavirus (COVID-19) death toll continues to escalate.What Happened At the daily White House coronavirus briefing, Trump described himself as a "cheerleader for our country" but struck a somber note speaking about possible fatalities. White House officials are predicting the death toll from COVID-19 could range from 100,000-240,000 Americans.Recognizing the devastating effect of COVID-19, Trump said, "When you look at night, the kind of death that has been caused by this invisible enemy, it's incredible."Benzinga is covering every angle of how the coronavirus affects the financial world. For daily updates, sign up for our coronavirus newsletter.Why It Matters According to the Johns Hopkins Coronavirus Resource Center, as of Wednesday, the United States had 189,624 COVID-19 cases, which is more than any other country in the world. The hardest-hit state has been New York. New York City alone has seen 43,119 cases and more than 1,096 deaths.The outbreak in New York may not peak for three weeks, according to the state's Governor Andrew Cuomo.Nationally, the fatalities are set to peak over the next two weeks, according to Dr. Deborah Birx, coordinator for the White House coronavirus task force and Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, as reported by CNBC.See more from Benzinga * Trump Signs Coronavirus Relief Bill, ECB Injects 1B In Liquidity, Japan Considers Cash Payouts * Health Care Dominates Sanders-Biden Debate, Promises Of Female Vice President Made * US Stocks, Dollar Decline After Trump Announces Suspension Of Travel From Europe(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Stocks ended Tuesday’s session lower, closing out the worst quarter for the Dow since 1987 and its first three-month start to the year on record.